Screening Interventions for Early-Onset Colorectal Cancer
(PRECISE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial investigates ways to improve colorectal cancer screening for younger Veterans, specifically those aged 45-49. It aims to develop a method to identify individuals at higher risk of early-onset colorectal cancer and encourage preventive steps. The trial includes different groups: some patients will receive information about their risk (patient intervention), some providers will be informed (PCP intervention), and some both. It seeks participants who have not had a recent colonoscopy or FIT test and have no history of colorectal cancer. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance early detection and prevention strategies for colorectal cancer.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this screening intervention is safe for early-onset colorectal cancer?
Research has shown that having a primary care doctor can improve outcomes in colorectal cancer (CRC) screening. Studies indicate that patients with a primary care doctor are 54% less likely to receive a late-stage CRC diagnosis compared to those without one. This involvement in screening proves beneficial and well-received.
Providing patients with personal support and information about screening is safe and poses no known issues. Involving both patients and their doctors together appears promising, leading to more discussions about CRC screening without any reported negative effects.
Overall, these efforts focus on educating and involving people rather than performing medical procedures, resulting in no major safety concerns. The aim is to encourage more screenings, which can detect cancer early and lead to better treatment outcomes.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to improve early detection of colorectal cancer, particularly in younger populations. Unlike traditional approaches that rely heavily on patient-initiated screenings or physician recommendations, this trial tests several new intervention strategies: one that involves direct patient engagement, another that targets primary care providers (PCPs), and a combined approach involving both. By exploring these different methods, researchers hope to identify the most effective way to encourage timely screenings and potentially catch cancer earlier, ultimately improving patient outcomes.
What evidence suggests that this trial's interventions could be effective for early-onset colorectal cancer?
Research has shown that having a regular primary care doctor can greatly improve outcomes for early-onset colorectal cancer. Studies have found that patients with a regular doctor are 54% less likely to be diagnosed with advanced colorectal cancer, highlighting the importance of doctors in screening and prevention. In this trial, participants may receive different interventions: some will receive a patient-focused intervention, others a primary care provider (PCP) intervention, and some both. These interventions aim to enhance early detection and improve survival chances. Findings suggest that both regular doctor visits and patient actions can help catch the cancer early and improve survival chances.14678
Who Is on the Research Team?
Peter S Liang, MD MPH
Principal Investigator
VA NY Harbor Healthcare System, New York, NY
Are You a Good Fit for This Trial?
This trial is for Veterans aged 45-49 years who are at risk of early-onset colorectal cancer (EOCRC). It aims to engage them in screening programs. Participants must be eligible for VA health care services but specific inclusion and exclusion criteria details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Conduct a multilevel screening intervention targeting individuals aged 45-49 years, informing high-risk individuals and their providers about their risk status for EOCRC
Follow-up
Participants are monitored for screening participation rates and effectiveness of the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Patient intervention
- PCP intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor